Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.99M | -11.06M | -10.84M | -8.54M | -11.98M |
| Total Depreciation and Amortization | 253.40K | 233.40K | 211.00K | 106.70K | 82.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.63M | 3.81M | 3.93M | -784.80K | 1.66M |
| Change in Net Operating Assets | -1.40M | -3.40M | -3.27M | -812.90K | 2.40M |
| Cash from Operations | -8.51M | -10.42M | -9.96M | -10.03M | -7.84M |
| Capital Expenditure | -107.10K | -115.80K | -110.80K | 12.40K | 12.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.71M | 17.27M | 14.54M | 9.55M | 1.89M |
| Cash from Investing | 9.60M | 17.15M | 14.43M | 9.56M | 1.90M |
| Total Debt Issued | 1.75M | 2.75M | 2.75M | 2.75M | 1.00M |
| Total Debt Repaid | -1.75M | -2.75M | -2.75M | -2.75M | -1.00M |
| Issuance of Common Stock | 5.00M | 265.90K | 265.70K | 265.40K | 265.40K |
| Repurchase of Common Stock | -10.30K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.70K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 4.92M | 264.90K | 265.70K | 265.40K | 265.40K |
| Foreign Exchange rate Adjustments | 35.50K | 183.70K | 173.70K | 79.40K | 128.50K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 6.05M | 7.18M | 4.90M | -128.20K | -5.55M |